miR-148b targets the WNT1/β catenin pathway and functions as a suppressor of cell proliferation and invasion in hepatocellular carcinoma (HCC), suggesting that it may be a possible target of HCC and may prove as a treatment strategy [120]. This evidence concerns the gene WNT1 and hepatocellular carcinoma.